定量临床核心脏病学(第2部分):应用进展及新技术  

Quantitative clinical nuclear cardiology,part 2:evolving/emerging applications

作　　者：Piotr J.Slomka Jonathan B.Moody Robert J.H.Miller Jennifer M.Renaud Edward P.Ficaro Ernest V.Garcia 王丽(译)[6] 杨敏福(审校)[6] Piotr J.Slomka;Jonathan B.Moody;Robert J.H.Miller;Jennifer M.Renaud;Edward P.Ficaro;Ernest V.Garcia;Wang Li;Yang Minfu(Department of Imaging(Division of Nuclear Medicine),Medicine,and Biomedical Sciences,Cedars-Sinai Medical Center,Los Angeles,CA;INVIA Medical Imaging Solutions,Ann Arbor,MI;Department of Cardiac Sciences,University of Calgary,Calgary,AB,Canada;Division of Cardiology,Department of Internal Medicine,University of Michigan,Ann Arbor,MI;Department of Radiology and Imaging Sciences,Emory University,Atlanta,GA;不详)

机构地区：[1]Department of Imaging(Division of Nuclear Medicine),Medicine,and Biomedical Sciences,Cedars-Sinai Medical Center,Los Angeles,CA [2]INVIA Medical Imaging Solutions,Ann Arbor,MI [3]Department of Cardiac Sciences,University of Calgary,Calgary,AB,Canada [4]Division of Cardiology,Department of Internal Medicine,University of Michigan,Ann Arbor,MI [5]Department of Radiology and Imaging Sciences,Emory University,Atlanta,GA [6]首都医科大学附属北京朝阳医院核医学科,北京100020

出　　处：《中华核医学与分子影像杂志》2022年第9期568-576,共9页Chinese Journal of Nuclear Medicine and Molecular Imaging

摘　　要：定量分析已广泛用于核心脏病学图像的处理和解读、改进疾病诊断和危险分层。该文为继续教育文章(含2部分)的第2部分,将对新兴的定量分析工具的临床潜在应用进行综述,介绍机械运动同步性、心室功能、灌注和融合显像定量分析技术,对PET和SPECT评估心肌血流量的新方法进行讨论。心肌活性、微钙化定量检测及心脏结节病和心脏淀粉样变的定量评估亦在文中描述。人工智能在改善图像分析、提高疾病诊断效能和风险预测方面的潜在作用将在文末进行论述。上述新技术的临床潜在应用及优化实施方法将在文中重点阐述。

关 键 词：核心脏病学 心肌血流量 定量 人工智能 相位分析 

分 类 号：R817.4[医药卫生—影像医学与核医学] R54[医药卫生—放射医学]